Healthcare -
Biotechnology - NASDAQ - US
$ 5.33
-3.09 %
$ 47.5 M
Market Cap
-10.88
P/E
ICCC - REVENUE
Revenue ICCC - ImmuCell Corporation
17.5 M
LAST VALUE
-4.71%
2 YEAR CAGR
9.72%
5 YEAR CAGR
11.27%
10 YEAR CAGR